| Joseph Peter Saginor, PHD | |
|
20 W Park St, Suite 209, Lebanon, NH 03766-1378 | |
| (603) 448-1553 | |
| (603) 675-5110 |
| Full Name | Joseph Peter Saginor |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 20 W Park St, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013927870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | #252 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Peter Saginor, PHD Po Box 493, Lebanon, NH 03766-0493 Ph: (603) 448-1553 | Joseph Peter Saginor, PHD 20 W Park St, Suite 209, Lebanon, NH 03766-1378 Ph: (603) 448-1553 |
News Archive
The Wall Street Journal reports on the challenges of calculating future income and health insurance subsidies - both of which will have an impact on the health law's new insurance marketplaces. Meanwhile, The Washington Post reports on how executive-branch and legislative-branch employees will have different experiences with the overhaul.
Seven million Medicare beneficiaries who are eligible for low-income transitional assistance and additional discounts can see very large savings on their prescription drugs through their Medicare-Approved Drug Discount Cards.
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow.
When faced with even a modest health insurance co-payment for a mammogram, significantly fewer women receive these potentially life-saving breast cancer screenings, according to a new study by Brown University and Harvard Medical School researchers.
Accumetrics, Inc., developer and marketer of the VerifyNow System, today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety) Trial found that in patients with high residual platelet reactivity, doubling the maintenance dose of clopidogrel did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).
› Verified 7 days ago
Jesse White, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9 Hanover St, Suite 2, Lebanon, NH 03766 Phone: 603-448-0126 | |
Dr. Michael W Mills, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Po Box 766, Lebanon, NH 03766 Phone: 603-667-8632 | |
Katrina Stephanie Hacker, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7075 | |
Dr. Stephen T Cole, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth Hitchcock - Psychology, Lebanon, NH 03756 Phone: 603-653-9146 | |
Dr. Mark P. Mcgovern, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 85 Mechanic St, Suite B4-1, Lebanon, NH 03766 Phone: 603-381-1160 Fax: 603-448-3976 | |
Courtney J Stevens, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7232 |